Document is current
Any future updates will be listed below
-
Authors
Tanoue, Susumu https://orcid.org/0009-0009-2875-3980
Saito, Takeshi
Yokoyama, Hiroki
Ishii, Hiroto
Ouchi-Nakano, Aya
Hosoba, Rika
Hattori, Daiki
Sato, Kohei
Motohashi, Saya
Nishiwaki, Kaichi
Dobashi, Nobuaki
Yano, Shingo
- License Information
-
More Information
Article History
Received: 22 April 2025
Revised: 28 August 2025
Accepted: 29 August 2025
First Online: 12 September 2025
Declarations
:
: H. Yokoyama reports research funding from Shionogi Pharmaceuticals outside the submitted work; K. Nishiwaki reports research funding from Alexion Pharmaceuticals, personal fees from Alexion Pharmaceuticals, Argenx Japan K.K. and Pfizer Japan outside the submitted work; N. Dobashi reports personal fees from Otsuka Pharmaceuticals outside the submitted work; S. Yano reports research funding from Otsuka Pharmaceuticals, Lilly Pharma and Fuji pharmaceuticals, personal fees from Astra Zeneca K.K. and Daiichi Sankyo outside the submitted work;.the other authors declare that they have no conflict of interest.
